Skip to main content

Advertisement

SpringerLink
Log in

Abdominal and pelvic imaging findings associated with sex hormone abnormalities

  • Review
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Hormones are substances that serve as chemical communication between cells. They are unique biological molecules that affect multiple organ systems and play a key role in maintaining homoeostasis. In this role, they are usually produced from a single organ and have defined target organs. However, hormones can affect non-target organs as well. As such, biochemical and hormonal abnormalities can be associated with anatomic changes in multiple target as well as non-target organs. Hormone-related changes may take the form of an organ parenchymal abnormality, benign neoplasm, or even malignancy. Given the multifocal action of hormones, the observed imaging findings may be remote from the site of production, and may actually be multi-organ in nature. Anatomic findings related to hormone level abnormalities and/or laboratory biomarker changes may be identified with imaging. The purpose of this image-rich review is to sensitize radiologists to imaging findings in the abdomen and pelvis that may occur in the context of hormone abnormalities, focusing primarily on sex hormones and their influence on these organs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14
Fig. 15
Fig. 16
Fig. 17
Fig. 18
Fig. 19

Similar content being viewed by others

References

  1. Conn P.M (2005). Introduction to Endocrinology. In: Melmed S., Conn P.M. (eds) Endocrinology. Humana Press: Totowa.

    Google Scholar 

  2. Hata S, Miki Y, Saito R, et al. (2013) Aromatase in human liver and its diseases. Cancer Medicine 2:305-315.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Yager JD, Davidson NE. (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med; 354:270-282.

    Article  CAS  PubMed  Google Scholar 

  4. Onstad MA, Schmandt RE, Lu KH. (2016) Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol; 34: 4225-4230

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Harada N, Ota H, Yoshimura N, Katsuyama T, Takagi Y. (1998) Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver. J Clin Endocrinol Metab; 83: 697-702.

    CAS  PubMed  Google Scholar 

  6. Wenniger LM, Terpstra V, Beuers U. (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg; 27:24-31.

    Article  Google Scholar 

  7. Kaltenbach TE, Engler P, Kratzer W, et al. (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol; 41:25-32.

    Article  PubMed Central  Google Scholar 

  8. Karhunen PJ. (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol; 39:183-188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Venturi A, Piscaglia F, Vidili G, et al. (2007) Diagnosis ad management of hepatic focal nodular hyperplasia. J Ultrasound; 10:116-127.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Grazioli L, Abrosini R, Frittoli B, Grazioli M, Morone M. (2017) Primary benign liver lesions. Eur J Radiol; 95: 378-398.

    Article  PubMed  Google Scholar 

  11. Fodor M, Primavesi F, Braunwarth E, et al. (2018) Indications for liver surgery in benign tumours. Eur Surg; 50: 125-131.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ringe KI, Husarik DB, Sirlin CB, Merkle EM. (2010) Gadoxetate disodium-enhanced MRI of the liver: part I, protocol optimization and lesion appearance in the noncirrhotic liver. Am J Roentgenol; 195:13-28.

    Article  Google Scholar 

  13. Grazioli L, Bondioni MP, Haradome H, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology; 262: 520-529.

    Article  PubMed  Google Scholar 

  14. Casarella WJ, Knowles DM, Wolff M, Johnson PM. (1976) Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation. Am J Roentgenol; 131:393-402.

    Article  Google Scholar 

  15. Venkatesh K. (2014) Liver masses: a clinical, radiological, and pathological perspective for: Perspectives in clinical gastroenterology and hepatology. Clin Gastroenterol Hepatol; 12: 1414-1429.

    Article  PubMed  Google Scholar 

  16. Virgilio E, Cavallini M. (2018) Managing focal nodular hyperplasia of the liver: surgery or minimally invasive approaches? A review of the preferable treatment options. Anticancer Res; 38: 33-36.

    Article  PubMed  Google Scholar 

  17. Kuo YH, Wang JH, Lu SN, et al. (2009) Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound; 37: 132-137.

    Article  PubMed  Google Scholar 

  18. Agrawal S, Agarwal S, Arnason T, et al. (2015) Management of hepatocellular adenoma: recent advances. Clin Gastroenterol Hepatol; 7:1221-1230

    Article  Google Scholar 

  19. Stoot J, Coelen R, de Jong MC, Dejong C. (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford); 12:509-522.

    Article  Google Scholar 

  20. Grazioli L, Federle M, Brancatelli G, et al. (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics; 21: 877-894.

    Article  CAS  PubMed  Google Scholar 

  21. Van Aalten SM, Thomeer MGJ, Terkivatan T, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classifications. Radiology; 261:172-181.

    Article  PubMed  Google Scholar 

  22. Reizine E, Amaddeo G, Pigneur F, et al. (2018) Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions. Eur Radiol.https://doi.org/10.1007/s00330-018-5438-7

    Article  PubMed  Google Scholar 

  23. Guo Y, Li W, Xie Z, et al. (2017) Diagnostic value of Gd-EOB-DTPA-MRI for hepatocellular adenoma: a meta-analysis. J Cancer; 8:1301-1310.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Agarwal S, Fuentes-Orrego JM, Amason T, et al. (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. Am J Roentgenol; 203: W408-414.

    Article  Google Scholar 

  25. Cobey FC, Salem RR. (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg; 187: 181-191.

    Article  PubMed  Google Scholar 

  26. Thomeer MG, Broker M, Verheij J, et al. (2016) Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol; 9: 898-912.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Almashhrawi AA, Ahmed KT, Rahman RN, Hammoud GM, Ibdah JA. (2013) Liver diseases in pregnancy: diseases not unique to pregnancy. World J Gastroenterol; 19: 7630-7638.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Bonnar J. (1987) Coagulation effects of oral contraception Am J Obstet Gynecol; 157:1042-1048.

    Article  CAS  PubMed  Google Scholar 

  29. Bissonnette J, Durand F, de Raucourt E, et al. (2015) Pregnancy and vascular liver disease. J Clin Exp Hepatol; 5:41-50.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Shin N, Kim YH, Xu H, et al. (2016) Redefining Budd-Chiari syndrome: a systematic review. World J Hepatol; 8: 691-702.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Dilawari J.B., Bambery P., Chawla Y. (1994) Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore);73:21–36.

    Article  CAS  Google Scholar 

  32. Brancatelli G, Vilgrain V, Federle MP, et al. (2007) Budd-Chiari syndrome: spectrum of imaging findings. Am J Roentgenol; 188: W168-W176.

    Article  Google Scholar 

  33. Ferra H, Behrens G, Lopera J. (2012) Budd-Chiari syndrome. Am J Roentgenol; 199: 737-745.

    Article  Google Scholar 

  34. Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology; 210:443–450

    Article  CAS  PubMed  Google Scholar 

  35. Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. (2002) Large regenerative nodules in Budd- Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinico- pathologic correlation. Am J Roentgenol; 178:877–883.

    Article  Google Scholar 

  36. Ruh J, Malago M, Busch Y, et al. (2005) Management of Budd-Chiari syndrome. Dig Dis Sci; 50:540–546

    Article  PubMed  Google Scholar 

  37. Jha RC, Khera SS, Kalaria AD. (2018) Portal vein thrombosis: imaging the spectrum of diseases with an emphasis on MRI features. Am J Roentgenol; 211:14-24.

    Article  Google Scholar 

  38. Davidson KG, Dubinsky TJ. (2003) Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin N Am; 41:769-780.

    Article  PubMed  Google Scholar 

  39. Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA; 280:1510-1517.

    Article  CAS  PubMed  Google Scholar 

  40. Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. (2016) Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol; 27:e8.

    Article  CAS  PubMed  Google Scholar 

  41. Freeman SJ, Aly AM, Kataoka MY, et al. (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics; 32:1805-1827.

    Article  PubMed  Google Scholar 

  42. Achiron R, Grisaru D, Golan-Porat N, Lipitz S. (1996) Tamoxifen and the uterus: an old drug tested by new modalities. Ultrasound Obstet Gynecol; 7:374-378.

    Article  CAS  PubMed  Google Scholar 

  43. Nougaret S, Horta M, Sala E, et al. (2018) Endometrial cancer MRI stating: updated guidelines of the European Society of Urogenital Radiology. Eur Radiol. https://doi.org/10.1007/s00330-018-5515-y

    Article  PubMed  PubMed Central  Google Scholar 

  44. Huo D, Anderson D, Palmer JR, Herbst AL. (2017) Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: update after 40-year follow up. Gynecologic Oncology; 146:566-571.

    Article  CAS  PubMed  Google Scholar 

  45. Gilles R, Michel G, Chancelier MD, Vanel D, Masselot J. (1993) Case report: clear cell adenocarcinoma of the vagina: MR features. Br J Radiol;66:168-70.

    Article  CAS  PubMed  Google Scholar 

  46. Parikh JH, Barton DPJ, Ind TEJ, Sohaib SA. (2008) MR imaging features of vaginal malignancies. Radiographics; 28:49-63.

    Article  PubMed  Google Scholar 

  47. Williams T, Mortada R, Porter S. (2016) Diagnosis and treatment of polycystic ovary syndrome. Am Fam Phys; 94:106-113.

    Google Scholar 

  48. Lee TT, Rausch ME. (2012) Polycystic ovarian syndrome: role of imaging in diagnosis. Radiographics; 32: 1643-1657.

    Article  PubMed  Google Scholar 

  49. Lujan ME, Chizen DR, Pierson RA. (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Can; 30: 671-679.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Teede HJ, Misso ML, Costelo MF, et al. (2018) International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. https://doi.org/10.1111/cen.13795

    Article  Google Scholar 

  51. Fitzgerald S, Divasta A, Gooding H. (2018) An update on PCOS in adolescents. Curr Opin Pediatr; 30:459-465.

    PubMed  Google Scholar 

  52. Babagbemi KT, Arleo EK, Asrani AV, Troiano RN. (2013) Emergent complications of assisted reproduction: expecting the unexpected. Radiographics; 33:229-244.

    Article  PubMed  Google Scholar 

  53. Lurain JR. (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation, and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol; 203: 531-539.

    Article  PubMed  Google Scholar 

  54. Lurain JR. (2011) Gestational trophopblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol; 204: 11-18.

    Article  PubMed  Google Scholar 

  55. Shaaban AM, Rezvani M, Haroun RR, et al. (2017) Gestational trophoblastic disease: clinical and imaging features. Radiographics; 37: 681-700.

    Article  PubMed  Google Scholar 

  56. Stenman UH, Alfthan H, Hotakainen K. (2004) Human chorionic gonadotropin in cancer. Clin Biochem; 37:549-561.

    Article  CAS  PubMed  Google Scholar 

  57. Hotakainen K. (2002) The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br J Cancer; 86:185-189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Shimomura T. (2005) Sarcomatoid renal cell carcinoma with a chromophobe component producing beta-human chorionic gonadotropin. Int J Urol; 12: 835-837.

    Article  CAS  PubMed  Google Scholar 

  59. Rukundo J, Ntasumbumuyange D, Small M, Rulisa S, Bazzett-Matabele L. (2017) Theca lutein cysts in the setting of primary hypothyroidism. Ultrasound in Obstetrics and Gynecology; 50: EP25.13.

    Google Scholar 

  60. Jung BG, Kim H. (2001) Severe spontaneous ovarian hyperstimulation syndrome with MR findings. J Comput Assist Tomogr; 25: 215-217.

    Article  CAS  PubMed  Google Scholar 

  61. Woodward PJ, Sohaey R, Mezzetti TP. (2001) Endometriosis: radiologic-pathologic correlation. Radiographics; 21: 193-216.

    Article  CAS  PubMed  Google Scholar 

  62. Glastonbury CM. (2002) The shading sign. Radiology; 224:199-201.

    Article  PubMed  Google Scholar 

  63. Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP. (2013) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology; 271:126-132.

    Article  PubMed  Google Scholar 

  64. McDermott S, Oei TN, Iyer VR, Lee SI. (2012) MR imaging of malignancies arising in endometriomas and extra-ovarian endometriosis. Radiographics; 32:845-863.

    Article  PubMed  Google Scholar 

  65. Levine D, Brown DL, Andreotti RF, et al. (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology; 256:943-954.

    Article  PubMed  Google Scholar 

  66. Outware EK, Wagner BJ, Mannion C, et al. (1998) Sex cord-stromal and steroid cell tumors of the ovary. Radiographics; 18: 1523-1546.

    Article  Google Scholar 

  67. Jung SE, Rha SE, Lee JM, et al. (2005) CT and MRI findings of sex cord-stromal tumor of the ovary. Am J Roentgenol; 185:207-215.

    Article  Google Scholar 

  68. Horta M, Cunha TM, Marques RC, Felix A. (2014) Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review. Radiology Case; 8:30-41.

    Article  PubMed  Google Scholar 

  69. McGill FM, Ritter DB, Rickard CS, et al. (1999) Krukenberg tumors: can management be improved? Gynecol Obstet Invest; 48:61-65.

    Article  CAS  PubMed  Google Scholar 

  70. Bacchus H. (ed) (1975) Amenorrhea. In: Essentials of Gynecologic and Obstetric Endocrinology. Springer: Dordrecht. https://doi.org/10.1007/978-94-011-9834-9_6.

  71. Syed FA, Oursler MJ, Hefferanm TE, et al. (2008) Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int; 19:1323-1330.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA

    Nicole Kurzbard-Roach, Priyanka Jha & Liina Poder

  2. Department of Radiology, Mayo Clinic, Scottsdale, AZ, USA

    Christine Menias

Authors
  1. Nicole Kurzbard-Roach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priyanka Jha
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liina Poder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine Menias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Priyanka Jha.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kurzbard-Roach, N., Jha, P., Poder, L. et al. Abdominal and pelvic imaging findings associated with sex hormone abnormalities. Abdom Radiol 44, 1103–1119 (2019). https://doi.org/10.1007/s00261-018-1844-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-018-1844-1

Keywords

Search

Navigation